NobleGen Biosciences holds exclusive license from Harvard and BU to commercialize breakthrough fourth-generation nanopore sequencing technology. Boston University Professor Amit Meller, an internationally recognized leader in nanopore physics, developed the technology. He has won $8.5 million in NIH funding since 2002. NobleGen is run by Meller and CEO Frank Feist and operates out of UMass [...]
Follow us on Twitter!
What we’re talking about2011 Amit Meller Azatuhi Ayrikyan biomedical engineering biosensor Boston Boston University British Geological Survey BU BU engineering business incubation BU Today Camera Mouse CAS clean-tech clean energy Coulter CTSI detection diagnostic tools Digital Lumens discoveries emerging markets Energy energy conservation Engineering entrepreneurs Frank Feist Fraunhofer Fraunhofer USA funding GATE GE geology Global Accelorators of Technology Entrepreneurship Good Start Genetics Ignition Awards innovation research Sean Lee Start-Up survey TDRR Tech Drugs & Rock 'n Roll technology